SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP
• By The Rose Sheet
SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP under a top-level management reshuffling announced July 7. Effective Sept. 1, Schering-Plough Exec VP Donald Conklin, 57, who has directed the company's worldwide prescription drug business since 1986, will become president of Schering-Plough HealthCare, replacing David Collins. Schering-Plough HealthCare's brands include Coppertone, Shade and Tropical Blend sunscreens and Dr. Scholl's foot care products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.
Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.
Arbonne International’s Hair Care Collection Scalp Elixir demonstrated improvement in scalp buildup in 96% of participants in a small study. Separately, It’s a 10 Haircare has extended with a new range, F.A.S.T. Haircare, clinically proven to grow hair up to 99% faster; Beauty Launch Roundup